Aster DM Healthcare Share Price Jumps 9% Amid Heavy Volumes, Hits All-Time High; Do You Own?

Aster DM Healthcare share price rose strongly due to high trading volumes, with over 1.2 crore shares traded on the NSE,14 times the usual amount. share Price jumped over 8% to close at Rs 644.

The share made its new 52-week high of Rs 674 on July 3, leading gains in the BSE 'A' group. This growth comes as Aster outperformed the healthcare sector, which itself rose 0.4%.

Stock Movement:

Aster DM Healthcare closed at Rs 650.05 on Thursday, July 3, gaining Rs 56.85 or 9.58% for the day. The stock had opened at Rs 595, hit a high of Rs 674, while the opening price was its lowest on the National Stock Exchange (NSE). The stock's 52-week low was at Rs 315.50.

Aster DM Healthcare's trading volume was 27.33 times compared to its 1-week average volume of 7%. The company's current market value (market capitalisation) is Rs 33,600 crore.

Technical View:

"Aster DM Healthcare has broken out of a six-week consolidation range, showing strong upward momentum. This breakout has already pushed the stock higher, and there is potential for another leg of the rally. Based on the current trend, the stock is expected to move towards a short-term target of Rs 685 to Rs 720 within the next 7 to 10 days. The suggested strategy is to buy and accumulate the stock with a stop loss set at Rs 610," said Rajesh Palviya, Head of Technical and Derivative Research at Axis Securities.

"Additionally, there was a sharp increase in trading volume, especially in the last half hour of the session. This volume surge indicates possible buying by institutional or high-net-worth investors. The strong buying activity adds confidence that the stock could see further gains in the near term. Similar trading behavior was observed in March 2025, which also led to a positive move," added Rajesh Palviya of Axis Securities.

Rajesh Palviya further said that, "Hospital stocks like Medanta, Fortis, Apollo, and Max Healthcare are currently in an uptrend, with many trading near their all-time highs. Specifically, Medanta has broken out of a six-week consolidation phase, showing strong upward momentum."

Aster DM Healthcare Performance:

Over the past year, Aster's stock gained nearly 87%, rising from Rs 300 to Rs 650, much higher than the BSE Healthcare index's 19% rise. The stock has given staggering 269% in 3 years and 434% rise in 5 years. The stock is trading above all key moving averages, showing a strong upward trend.

Financially, Aster DM Healthcare reported a 114% jump in net profit to Rs 95.6 crore for the quarter ending March 2025, with net sales up by 2.7%. For the full year FY25, the company's revenue grew 12% to Rs 4,138 crore, and profit increased 49% to Rs 357 crore. The growth was driven by more patient visits and better operational efficiency, boosting profit margins.

About Aster DM Healthcare:

Founded in 1987 by Dr. Azad Moopen, Aster DM Healthcare is headquartered in Dubai, United Arab Emirates. It is a healthcare service provider that operates across four main segments: hospitals, clinics, retail pharmacies, and other services. The hospitals segment includes the management of hospitals and their in-house pharmacies, while the clinics segment covers various outpatient clinics along with their own pharmacies.

The retail pharmacies segment consists of standalone pharmacy stores and optical outlets. The 'others' segment offers healthcare consulting and related services. Its strong recent performance has helped hospital stocks like Max Healthcare and Apollo Hospitals also reach new highs.

Disclaimer: The recommendations made above are by market analysts and are not advised by either the author, nor GoodReturns. The author, nor the brokerage firm nor GoodReturns would be liable for any losses caused as a result of decisions based on this write-up. Goodreturns.in advises users to consult with certified experts before making any investment decision.